These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 26792308)

  • 1. Targeting composite treatment of type 2 diabetes in middle-income countries--walking a tightrope between hyperglycaemia and the dangers of hypoglycaemia.
    Wing J; Jivan D
    S Afr Med J; 2015 Dec; 106(1):57-61. PubMed ID: 26792308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
    Noh RM; Graveling AJ; Frier BM
    Expert Opin Pharmacother; 2011 Oct; 12(14):2161-75. PubMed ID: 21668402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediterranean studies of cardiovascular disease and hyperglycemia: analytical modeling of population socio-economic transitions (MedCHAMPS)--rationale and methods.
    Maziak W; Critchley J; Zaman S; Unwin N; Capewell S; Bennett K; Unal B; Husseini A; Romdhane HB; Phillimore P
    Int J Public Health; 2013 Aug; 58(4):547-53. PubMed ID: 23111372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in funding diabetes care: a health economic perspective.
    Weber C
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):517-24. PubMed ID: 20950068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes.
    Barnett AH; Cradock S; Fisher M; Hall G; Hughes E; Middleton A
    Int J Clin Pract; 2010 Jul; 64(8):1121-9. PubMed ID: 20236369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Special considerations for the diabetic patient in the ICU; targets for treatment and risks of hypoglycaemia.
    Siegelaar SE; Hoekstra JB; DeVries JH
    Best Pract Res Clin Endocrinol Metab; 2011 Oct; 25(5):825-34. PubMed ID: 21925081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of health systems on diabetes care in low and lower middle income countries.
    Beran D
    Curr Diab Rep; 2015 Apr; 15(4):20. PubMed ID: 25721248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.
    Mathur SK; Bansal A; Khan ZY
    J Indian Med Assoc; 2009 Nov; 107(11):759-61. PubMed ID: 20469779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycaemia: costs, insulins and prevention.
    Holt RI
    Diabet Med; 2016 Apr; 33(4):419-20. PubMed ID: 26995756
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
    Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
    Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The double burden of communicable and non-communicable diseases in developing countries.
    Boutayeb A
    Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):191-9. PubMed ID: 16274715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structuring Diabetes Mellitus Care in Long-Term Nursing Home Residents.
    Fitzpatrick D; Ibrahim ES; Kennelly S; Sherlock M; O'Neill D
    Ir Med J; 2018 Mar; 111(3):711. PubMed ID: 30376229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
    Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
    BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-communicable diseases and health systems reform in low-and-middle-income countries.
    Robinson HM; Hort K
    Pac Health Dialog; 2012 Apr; 18(1):179-90. PubMed ID: 23240355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The older patient with diabetes: a practical approach.
    Yehuda AB; Zinger A; Durso S
    Diabetes Metab Res Rev; 2014 Feb; 30(2):88-95. PubMed ID: 24123811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What should a country spend on health care?
    Savedoff WD
    Health Aff (Millwood); 2007; 26(4):962-70. PubMed ID: 17630438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and costs of severe hypoglycaemia requiring attendance by the emergency medical services in South Central England.
    Farmer AJ; Brockbank KJ; Keech ML; England EJ; Deakin CD
    Diabet Med; 2012 Nov; 29(11):1447-50. PubMed ID: 22435781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium.
    Peene B; D'Hooge D; Vandebrouck T; Mathieu C
    Acta Clin Belg; 2014 Dec; 69(6):439-45. PubMed ID: 25212241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and Emerging Insulin Preparations for Type 2 Diabetes.
    Cheung KK; Alexander P
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S160-6. PubMed ID: 26653255
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of glucose fluctuation on cognitive function and QOL: the functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes.
    Cox D; Gonder-Frederick L; McCall A; Kovatchev B; Clarke W
    Int J Clin Pract Suppl; 2002 Jul; (129):20-6. PubMed ID: 12166601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.